Cover Image
Market Research Report

Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025

Published by AnalystView Market Insights Product code 737933
Published Content info 133 Pages
Delivery time: 1-2 business days
Price
Back to Top
Biosimilars Market, By Product Type (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Application And Geography - Analysis, Share, Trends, Size, & Forecast From 2014 - 2025
Published: July 30, 2017 Content info: 133 Pages
Description

Report Hightlights

The "Global Biosimilars Market- - Industry Analysis, Share, Trend, Market Size and Forecast" was estimated to be around US$ 50.0 billion in 2016 and is anticipated to grow with 55.0% of growth rate during the future period. This report segments the global Biosimilars Market by product type, application and geography. Biosimilars are the biologics pharmaceutical drugs which are similar to the reference biologic products. These drugs are an interchangeable biological product that contains synthetically developed protein molecules. When the patent of branded drug is expired, pharmaceutical companies are planning to develop off-patent biologics i.e. biosimilars that offer similar biological activity. The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of pharmaceutical drugs.

In terms of product types, the market for recombinant glycosylated proteins continue to dominate during the forecast period, while the market for recombinant non-glycosylated proteins biosimilars will see a huge potential during the forecast period. On other side, oncology was the largest application segment in 2016, and expected to be the fastest growing application segment in the forecast period. The rise in the aging population, increasing cancer patients, and rise of hospital acquired infection patients globally are factors responsible for the growth of this application segment. The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The report aims at estimating the market size and future growth potential of market across different segments, such as product types, application and regions. The years considered for the study are:

Historical Year - 2014 & 2015

Base Year - 2015

Estimated Year - 2016

Projected Year - 2025

Companies reported in this report are: Amgen, Inc, AstraZeneca, Pfizer, Inc., BIOCON Limited, Novartis AG, STADA, Teva Pharmaceuticals Inc. and Others. For company profiles in the report, 2014 has been considered. Where information is unavailable for the base year, the prior year has been considered.

TARGET AUDIENCE

Hospitals

Manufacturers

Traders, Distributors, And Suppliers of Biosimilars

Government and Regional Agencies and Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT:

The research report categorizes the Biosimilars Market in each of the following submarkets to forecast the revenues and analyze the trends:

GLOBAL BIOSIMILARS MARKET, BY PRODUCT TYPES

Recombinant Glycosylated Proteins

Recombinant Non-Glycosylated Proteins

Recombinant Peptides

GLOBAL BIOSIMILARS MARKET, BY APPLICATION

Oncology

Blood Disorders

Infectious Diseases

Autoimmune Diseases

Others

GLOBAL BIOSIMILARS MARKET, BY REGION

North America

Europe

Asia Pacific

Rest of the World

GLOBAL BIOSIMILARS MARKET, GEOGRAPHIC ANALYSIS

Further Breakdown of The North America Biosimilars Market

U.S.

Canada

Further Breakdown of The Europe Biosimilars Market

Germany

France

Rest of Europe

Further Breakdown of The APAC Biosimilars Market

India

China

Rest of APAC

Further Breakdown of The Rest of the World Biosimilars Market

Middle East and Africa

Latin America

Table of Contents
Product Code: AV134

TABLE OF CONTENTS

BIOSIMILARS MARKET OVERVIEW

Study Scope

Base Year

Assumption and Methodology

EXECUTIVE SUMMARY

Key Market Facts

Geographical Scenario

Companies in the Market

BIOSIMILARS MARKETKEY MARKET TRENDS

Market Drivers

Impact Analysis of Market Drivers

Market Restraints

Impact Analysis of Market Restraints

Market Opportunities

Market Future Trends

BIOSIMILARS MARKETINDUSTRY STUDY

Pipeline Therapeutic Analysis

Pricing Analysis

New Introduction by Leading Companies

BIOSIMILARS MARKET LANDSCAPE

Market Share Analysis

Key Innovators

BIOSIMILARS MARKET - BY PRODUCT TYPES:

Overview

Recombinant Glycosylated Proteins

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Recombinant Non-Glycosylated Proteins

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Recombinant Peptides

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

BIOSIMILARS MARKET - BY APPLICATION:

Overview

Oncology

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Blood Disorders

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Infectious Diseases

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Autoimmune Diseases

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Other Diseases

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

BIOSIMILARS MARKET- BY GEOGRAPHY

Introduction

North America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

U.S.

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Canada

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

France

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Germany

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of Europe

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Asia Pacific (APAC)

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

China

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

India

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of APAC

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Rest of the World

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Latin America

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

Middle East and Africa

Overview

Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

KEY VENDOR ANALYSIS

Astra Zeneca, plc

Company Overview

SWOT Analysis

Key Developments

Amgen, Inc.

Company Overview

SWOT Analysis

Key Developments

Pfizer, Inc.

Company Overview

SWOT Analysis

Key Developments

Biocon Ltd.

Company Overview

SWOT Analysis

Key Developments

Novartis AG

Company Overview

SWOT Analysis

Key Developments

Teva Pharma

Company Overview

SWOT Analysis

Key Developments

STADA AG

Company Overview

SWOT Analysis

Key Developments

360 DEGREE ANALYSTVIEW

APPENDIX

Research Methodology

Abbreviations

Disclaimer

Contact Us

SCOPE AND OBJECTIVES

The objective of this report is to describe the market trends and revenue forecasts for the Biosimilars Market for the upcoming years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the coil coatings market. The scope of this report covers the Biosimilars Market by its major segments, which include the type, end user industry, and the major geographic regions.

KEY BENEFITS OF THE REPORT:

Understanding of the strategies that are being adopted by the key players in this market to stay competitive

Extensive analysis of the key players dominating the competitive landscape of this market

In-depth analysis of the key factors are propelling the growth of the global market

Detailed analysis of the geographic region that will witness the strongest growth

Granular analysis of the current market scenario and the expected market grow

KEY PREMIUM INSIGHTS:

Rising consumer wealth and income levels, increasing government and patient awareness, and a trend towards healthier lifestyles are anticipated to boost health care spending to around 8.1% in 2014-2018 in Asia Pacific

Biosimilars require high costs of investment and require a time frame to 7-8 years to enter the market

Economic expansion and government focus on broader welfare policies will drive the market for biosimilars.

List of Tables

  • Table 1 List of Acronyms
  • Table 2 Key Market Facts, 2014 - 2025
  • Table 3 Market Drivers: Impact Analysis
  • Table 4 Market Restraint: Impact Analysis
  • Table 5 Market Opportunity: Impact Analysis
  • Table 6 PESTLE Analysis
  • Table 7 Porter's Five Forces Analysis
  • Table 8 Company Market Share Analysis
  • Table 9 Global Biosimilars Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • Figure 10 Biosimilars Market, by Product Type, 2014 - 2025 (USD Million)
  • Figure 11 Biosimilars Market, by Application, 2014 - 2025 (USD Million)
  • Figure 12 Biosimilars Market, by Geography, 2014 - 2025 (USD Million)
  • Table 13 North America Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 14 U.S. Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 15 Canada Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 16 Europe Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 17 France Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 18 Germany Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 19 Asia Pacific Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 20 China Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 21 India Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 22 Latin America Biosimilars Market, 2014 - 2025 (USD Million)
  • Table 23 MEA Biosimilars Market, 2014 - 2025 (USD Million)

List of Figures

  • Figure 1 Research Methdology
  • Figure 2 Research Process Flow Chart
  • Figure 3 Comparative Analysis, by Geography, 2016-2025 (Value %)
  • Figure 4 Regulatory Framework Analysis
  • Figure 5 Value Chain Analysis Analysis
  • Figure 6 Biosimilars Market, by Product Type, 2014 - 2025 (USD Million)
  • Figure 7 Biosimilars Market, by Application, 2014 - 2025 (USD Million)
  • Figure 8 Biosimilars Market, by Geography, 2014 - 2025 (USD Million)
Back to Top